drugset / Trial / NCT06516094

Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain

NCT06516094

Phase 3 Completed 192 enrolled Laboratorios Silanes S.A. de C.V.
RandomizedSequentialDouble-blindTreatment

Summary

Phase III longitudinal, multicenter, randomized, double-blind clinical trial. The aim of this study is to evaluate the efficacy and security of the drug combination of Celecoxib / Pregabalin / Vitamin B versus Celecoxib + Vitamin B, versus Pregabalin + Vitamin B in the treatment of chronic low back pain.

Timeline

Start
2024-04-11
Primary completion
2025-01-01
Completion
2025-01-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Subject Pregabalin Small molecule 150 mg Oral
Background Vitamin B12 Other / unclassified 0.5 mg Oral
Background pyridoxone hydrochloride Unknown 50 mg Oral
Background thiamine mononitrate Unknown 100 mg Oral

Indications